Hanna Falk Håkansson, MSc, Senior Scientist

Hanna has more than 15 years of experience of drug discovery with the main focus on in vivo pharmacology. The main focus has been inflammatory disease including work with both pharmacodynamics and disease mechanism models with the aim of characterizing and developing pharmaceutical drugs. Hanna has from her work at AstraZeneca R&D an expertise in respiratory diseases with emphasis on different techniques for measuring lung function alterations in rodents. At AstraZeneca R&D Hanna lead the work to include lung function as a read-out in both new and existing rodent models of asthma and COPD. The last couple of years Hanna has been working in the in vitro diagnostic industry, at HemoCue AB, as a test leader within design verification and validation of new products. Hanna joined Truly Labs as Senior Scientist in 2015.